Health Canada approves Amylyx’s Albrioza for ALS treatment
The latest approval is based on findings from a multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.
Clinical Trials
Latest in
Clinical Trials
Pfizer acquires biopharma firm ReViral for up to $525m
Pfizer will gain rights to ReViral’s portfolio of therapeutic candidates, including sisunatovir.
Everest’s Trodelvy receives approval for breast cancer in China
In a Phase IIb trial in 80 subjects, Trodelvy offered an overall response rate of 38.8%.
Alto Neuroscience uses AI to create biomarkers for personalised mental health drugs
GlobalData’s Drugs Database reveals that more than 490 unique drugs have been discovered using AI-based technologies.
By
Roche’s Evrysdi gets FDA approval for spinal muscular atrophy in babies
The latest approval is based on interim data from the RAINBOWFISH trial of Evrysdi in pre-symptomatic babies.
EC grants conditional approval for Janssen’s multiple myeloma cell therapy
The CMA is supported by the open-label, multi-centre Phase Ib/II CARTITUDE-1 clinical trial of cilta-cel to treat RRMM.
Laekna raises $61m to accelerate product development
The company launched six clinical programmes, with three multi-regional clinical trials for cancers.
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
The grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.